Boston Scientific (BSX) stock tumbled 9% to two-year lows after Watchman trial data revealed stroke concerns and Raymond ...
Boston Scientific Corporation BSX shares are down on Monday as the company faces pressure following a significant clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results